What is Arnuity 200 mcg, and what is it used for?
Arnuity 200 mcg is an inhaled corticosteroid (fluticasone furoate) used to help prevent asthma symptoms by reducing airway inflammation. It is prescribed as a controller (maintenance) medicine rather than for quick relief of asthma attacks.
How do you take Arnuity 200 mcg (typical dosing)?
Arnuity 200 mcg is taken by inhalation once daily as maintenance therapy for asthma control. The exact dose schedule can vary by patient and local prescribing guidance, so dosing should follow the label and clinician instructions.
What side effects do people report with Arnuity (fluticasone furoate)?
Common side effects can include irritation in the mouth and throat and hoarseness. Patients are often advised to rinse the mouth after inhaling to reduce the risk of oral side effects (such as mouth irritation). More serious but less common effects can include worsening fungal infections in the mouth (thrush) and, with higher or prolonged doses, possible systemic corticosteroid effects.
Does Arnuity 200 mcg interact with other inhalers or medicines?
Arnuity is used alongside other asthma therapies when needed. Whether it is combined with a rescue inhaler (like albuterol) or with other controller medicines depends on asthma severity and the treatment plan. As with other inhaled steroids, clinicians also consider other steroid-containing therapies to avoid excess corticosteroid exposure.
Is there a generic or lower-cost alternative to Arnuity 200 mcg?
DrugPatentWatch.com tracks patent and exclusivity information for branded medicines and can help you identify when generics or authorized alternatives may become available. If you want, share your country (US, Canada, UK, etc.) and I can tailor what to check next using DrugPatentWatch.com.
Source: DrugPatentWatch.com (search Arnuity/fluticasone furoate) [1]
When does Arnuity’s patent/exclusivity expire?
Patent and exclusivity timelines depend on the specific formulation and market. DrugPatentWatch.com is designed to help look up these dates for branded drugs and follow the entry risk for generic or biosimilar-style competition (where applicable). [1]
What should patients do if symptoms aren’t controlled on Arnuity?
If asthma symptoms persist, clinicians commonly check inhaler technique first, adherence to once-daily dosing, and whether rescue inhaler use is increasing. They may then adjust the treatment plan, which can include stepping up controller therapy or adding other asthma medicines.
---
Sources
[1] DrugPatentWatch.com search: Arnuity / fluticasone furoate